US 12168008
Oxabicycloheptanes for modulation of immune response
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 12168008 (Oxabicycloheptanes for modulation of immune response) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K31/4525